Research Article

Effect of Topical Brimonidine 0.15% on Conjunctival Injection after Strabismus Surgery in Children

Table 1

Baseline characteristics of patients receiving topical brimonidine 0.15% and the control group.

CharacteristicsBrimonidine (n = 32)Control (n = 31)Total (n = 63)P value

Sex (M : F)18 : 1418 : 1336 : 270.884
Laterality (R : L)15 : 1717 : 1432 : 310.527
Mean age (years)9.2 ± 1.1 (7.7–11.8)9.0 ± 1.0 (7.6–11.6)9.1 ± 1.0 (7.6–11.8)0.549
Cycloplegic refraction (D)−1.30 ± 1.61 (−5.25–+2.25)−1.34 ± 1.82 (−6.50–+1.25)−1.32 ± 1.70 (−6.50–+2.25)0.916
Angle of deviation (PD)
Distance23.2 ± 7.4 (12−45)22.8 ± 7.2 (12–45)23.0 ± 7.2 (12–45)0.824
Near29.9 ± 8.3 (15−45)27.0 ± 8.6 (12–40)28.5 ± 8.5 (12–45)0.177
Surgical dosage (mm)
Medial rectus muscle6.1 ± 0.9 (4.0–7.0)5.7 ± 1.2 (3.5–7.0)5.9 ± 1.0 (3.5–7.0)0.168
Lateral rectus muscle5.6 ± 1.2 (4.0–8.5)5.4 ± 1.2 (3.5–8.5)5.5 ± 1.2 (3.5–8.5)0.605

M = male; F = female; R = right; L = left; D = diopters; PD = prism diopters. value by Pearson’s χ2 test. value by independent t-test.